Stockscreener 앱 받기
0.9816
2.81%
-0.0284
시간 외 거래:
1.02
0.0384
+3.91%
Carisma Therapeutics Inc 주식(CARM)의 최신 뉴스
Carly Rae Jepsen is engaged! Canadian singer shares happy news on social media: 'Very engaged over here' - Yahoo Canada Shine On
Carly Rae Jepsen Flaunts Blue Engagement Ring with Grammy Winning Fiancé - 2paragraphs Buzz
CRDF (Cardiff Oncology Inc) has impressive results - US Post News
Berkley W R Corp Sells 451,295 Shares of Cartica Acquisition Corp (NASDAQ:CITE) - MarketBeat
Carly Rae Jepsen is a fiancée! Singer announces engagement to Grammy-winning producer - USA TODAY
Carly Rae Jepsen Engaged to Producer Cole MGN: See Her RingE! Online - E! NEWS
'Very engaged over here': Singer Carly Rae Jepsen announces her engagement to music producer Cole M.G.N. - 9Honey Celebrity
Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily
Surprise! Carly Rae Jepsen Is Engaged!!! - PerezHilton.com
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga
Carly Rae Jepsen announces engagement to boyfriend Cole MGN after two years of dating - Daily Mail
Carly Rae Jepsen Proclaims Herself ‘Very Engaged Over Here’ in Photoshoot Showing Off Ring From Fiancé Cole M.G.N. - Billboard
Carly Rae Jepsen Engaged to Producer Cole M.G.N. - AceShowbiz Media
Carly Rae Jepsen & Boyfriend Cole M.G.N. Are Engaged! - Just Jared
Cole M.G.N. Entertainment News, Photos, and Videos - Just Jared
A closer look at Cara Therapeutics Inc (CARA) is warranted - US Post News
Hancock Whitney Corp Has $737,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Where Are They Now? Carisma Therapeutics - Life Science Leader Magazine
Gabelli Funds LLC Has $120.74 Million Stake in Crane (NYSE:CR) - MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) PT Lowered to $40.00 at B. Riley - Defense World
Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard
Selling Buzz: Accuray Inc [ARAY] SVP Chief Financial Officer Pervaiz Ali sells 8,404 shares of the company - Knox Daily
A company insider recently sold 833 shares of Apollo Commercial Real Estate Finance Inc [ARI]. Should You Sale? - Knox Daily
Catalyst Pharmaceuticals (NASDAQ:CPRX) Hits New 1-Year High at $21.10 - MarketBeat
An analyst sees good growth prospects for Capricor Therapeutics Inc (CAPR) - SETE News
CMR Bolsters Funding for Mineral Exploration - TipRanks
Quest Partners LLC Purchases Shares of 934 Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Mutual of America Capital Management LLC Increases Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
CRISM Therapeutics Reports Positive Interim Results - TipRanks
Cairn Homes Advances Share Buyback Plan - TipRanks
Cero Therapeutics postpones special stockholders meeting By Investing.com - Investing.com Canada
Federated Hermes Inc. Sells 134 Shares of Cimpress plc (NASDAQ:CMPR) - Defense World
Aclaris Therapeutics neutral rating reiterated on phase 2a trial - Investing.com
Federated Hermes Inc. Acquires 399,860 Shares of Costamare Inc. (NYSE:CMRE) - Defense World
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
Review: AfrAId (2024) - It's A Stampede!
BTIG Research gives a Neutral recommendation for Apollo Commercial Real Estate Finance Inc (ARI) - Knox Daily
Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
What technical indicators reveal about CARA stock - US Post News
The time has not yet come to remove your chips from the table: Cara Therapeutics Inc (CARA) - SETE News
Cara Therapeutics Inc (CARA)’s Day in Review: Closing at 0.26, Down by -2.85 - The Dwinnex
Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases - MyChesCo
Carisma Therapeutics to Present at Upcoming Conferences - Kilgore News Herald
Carisma Therapeutics CEO to Present at Key Industry Conferences - MSN
Carisma and Moderna partner on autoimmune disease therapies By Investing.com - Investing.com Australia
CARM’s valuation metrics: A comprehensive analysis - US Post News
Carisma and Moderna partner on autoimmune disease therapies - Investing.com
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases - PR Newswire
Carisma Therapeutics CEO to Present at Key Industry Conferences - MyChesCo
Carisma Therapeutics to Present at Upcoming Conferences - Nasdaq
Carisma Therapeutics to Present at Upcoming Conferences - PR Newswire
The time has not yet come to remove your chips from the table: Carisma Therapeutics Inc (CARM) - SETE News
Can you now get a good deal on Carisma Therapeutics Inc’s shares? - US Post News
Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MSN
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023 - BioSpace
Vanguard Group Inc. Acquires 11,200 Shares of Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World
Carisma Therapeutics Reports Second Quarter 2023 Financial Resul - GuruFocus.com
Carisma Therapeutics (NASDAQ:CARM) Trading 6.7% Higher - Defense World
Carisma Therapeutics to Participate in Evercore ISI HealthCONx C - GuruFocus.com
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024 - Longview News-Journal
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan H - GuruFocus.com
Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders - Longview News-Journal
CARISMA THERAP (CARM) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Carisma Therapeutics Reports Progress and Financial Results for Q2 2024 - MyChesCo
Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MyChesCo
Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - citybiz
Carisma Therapeutics Inc. (CARM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Finance
Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - PR Newswire
Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board - citybiz
Carisma Therapeutics expands scientific advisory board - Investing.com
Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board - Citizentribune
Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board - The Malaysian Reserve
0.05%
4.86%
자본화:
|
볼륨(24시간):